PIIS0002937807011209
PIIS0002937807011209
PIIS0002937807011209
REPLY
Thank you for your thoughtful comments on our study. As you tal outcomes, the increase in gestational age at delivery saves
know, 1 of the key points in performing a cost analysis is de- money, mostly in neonatal intensive care unit costs. The results
ciding what studies to include in the estimates. Because medi- of this cost analysis do not eliminate the need for individual
cal costs and intensity of treatment vary greatly between coun- physicians to evaluate the available evidence and decide
tries, we chose to focus our cost estimates on the United States whether they feel comfortable with the risks and benefits of
alone. To infer the absolute (not proportional) decline in pre- prescribing a drug for a particular patient. f
term rates that could be expected, an estimate of the preterm
Jennifer Bailit, MD, MPH
birth rate was also needed from the US population. We ob- Division of Maternal-Fetal Medicine
tained the baseline risk of preterm birth for patients with a Department of Obstetrics and Gynecology
prior preterm birth from the paper by Mercer et al.1 MetroHealth Medical Center
The trial by Meis et al2 has been criticized for having a pre- 2500 MetroHealth Dr.
term birth rate that was quite high. Although some have spec- Cleveland, OH 44109
ulated that castor oil in the placebo given to the placebo group jbailit@metrohealth.org
increased the risk of preterm birth, there are no clinical data to Mark E. Votruba, PhD, MPP
support this assertion. The 17 ␣ hydroxyprogesterone caproate The Center for Health Care Research and Policy
in twins and triplets: a randomized study (STTARS) trial pre- MetroHealth Medical Center
sentation at the Society for Maternal-Fetal Medicine meeting Department of Economics
in 2007 showed a preterm birth rate in the placebo group that Weatherhead School of Management
was similar to national rates, suggesting that castor oil in the Case Western Reserve University
placebo does not cause preterm birth.3 More likely the trial by Cleveland, OH 44109
Meis et al attracted a motivated cohort of women who were at
very high risk for preterm birth. REFERENCES
Of course, if a treatment does not work, it will not be cost 1. Mercer BM, Goldenberg RL, Moawad AH, et al. The preterm prediction
effective. As noted, we chose the Meis estimates because they study: effect of gestational age and cause of preterm birth on subsequent
obstetric outcome. National Institute of Child Health and Human Devel-
were consistent with metaanalyses on the effectiveness of 17 opment Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol
alpha-hydroxyprogesterone caproate (17P). Reconstruction of 1999;181:1216-21.
our analysis based on 1 of these “metaestimates” with the ex- 2. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm
clusion of the Meis results would result in a larger cost savings. delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med
We chose to use the most conservative numbers. 2003;348:2379-85.
3. Caritis SN, Rouse DJ. A randomized controlled trial of 17-hydroxypro-
At the meeting of the Society for Maternal-Fetal Medicine in gesterone caproate (17-OHPC) for the prevention of preterm birth in
2007, 4-year child follow-up results from the Meis trial were twins. Am J Obstet Gynecol 2006;195:S2.
presented.4 The follow-up study was reassuring as to the safety 4. Northen A. 4-Year follow-up of children exposed to 17alpha hy-
of 17P. However, whether 17P ultimately is shown to improve droxyprogesterone caproate (17P) in utero. Am J Obstet Gynecol
long-term outcomes and not just perinatal outcomes is not 2006;195:S6.
critical to our study. Regardless of whether it improves neona- © 2007 Mosby, Inc. All rights reserved. doi: 10.1016/j.ajog.2007.09.023
REPLY
Thank you very much for your interest in our case.1 Baxi in- associated with placenta previa. For that reason, transverse
troduced a different approach to the management of the prom- hysterotomy in uterine corpus was performed. f
inent uterine varices during cesarean section. This approach
Koji Matsuo, M.D
was exactly opposite to what we had performed in our case.
Department of Obstetric, Gynecology, and Reproductive Sciences
Transverse hysterotomy in uterine corpus and hemostatic University of Maryland School of Medicine
clamp of uterine varices are both options for this rare compli- University of Maryland Medical Center
cation during pregnancy. Obstetricians need to be familiar 22 South Greene St.
with the pros and cons in both approaches. Hysterotomy in PO Box 290
uterine corpus gives a faster approach to delivery, although Baltimore, MD 21201
there may be an increased risk of uterine rupture in future kmats001@umaryland.edu
pregnancies. A hemostatic clamp of uterine varix requires me-
Tadashi Kimura, MD, PhD
ticulous surgical skills and may take longer but is doable with
Department of Obstetrics and Gynecology
low transverse hysterotomy. Circumstances surrounding ce-
Osaka University Graduate School of Medicine
sarean section are key in choosing the appropriate approach
Osaka, Japan
(eg, an emergent situation, a surgeon’s level of comfort, and
number and locations of uterine varices).
In our case, there were at least 5 large varices, and each vessel REFERENCE
was distended more than an index finger size. Furthermore, 1. Matsuo K, Kimura T. Uterine varices during pregnancy. Am J Obstet
Gynecol 2007;197:112.e1.
our concern at the time of cesarean section was the possible
hypervascularity within the wall of the uterine lower segment © 2007 Mosby, Inc. All rights reserved. doi: 10.1016/j.ajog.2007.09.020